Novo Nordisk AS (NVO)
111.94
-0.01
(-0.01%)
USD |
NYSE |
Nov 01, 16:00
112.22
+0.28
(+0.25%)
After-Hours: 20:00
Novo Nordisk 1 Year Total Returns (Daily): 15.87% for Nov. 1, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
November 01, 2024 | 15.87% |
October 31, 2024 | 17.21% |
October 30, 2024 | 18.77% |
October 29, 2024 | 21.09% |
October 28, 2024 | 21.50% |
October 25, 2024 | 17.66% |
October 24, 2024 | 18.11% |
October 23, 2024 | 20.49% |
October 22, 2024 | 22.30% |
October 21, 2024 | 23.20% |
October 18, 2024 | 18.72% |
October 17, 2024 | 18.16% |
October 16, 2024 | 17.98% |
October 15, 2024 | 16.62% |
October 14, 2024 | 18.57% |
October 11, 2024 | 22.79% |
October 10, 2024 | 27.76% |
October 09, 2024 | 28.50% |
October 08, 2024 | 28.64% |
October 07, 2024 | 29.26% |
October 04, 2024 | 30.72% |
October 03, 2024 | 32.55% |
October 02, 2024 | 28.29% |
October 01, 2024 | 31.20% |
September 30, 2024 | 32.38% |
Date | Value |
---|---|
September 27, 2024 | 33.15% |
September 26, 2024 | 36.92% |
September 25, 2024 | 40.85% |
September 24, 2024 | 38.92% |
September 23, 2024 | 36.99% |
September 20, 2024 | 36.10% |
September 19, 2024 | 45.82% |
September 18, 2024 | 43.10% |
September 17, 2024 | 40.17% |
September 16, 2024 | 45.37% |
September 13, 2024 | 43.82% |
September 12, 2024 | 40.46% |
September 11, 2024 | 37.04% |
September 10, 2024 | 34.31% |
September 09, 2024 | 36.51% |
September 06, 2024 | 38.66% |
September 05, 2024 | 39.23% |
September 04, 2024 | 43.70% |
September 03, 2024 | 45.55% |
August 30, 2024 | 49.63% |
August 29, 2024 | 46.08% |
August 28, 2024 | 45.04% |
August 27, 2024 | 46.63% |
August 26, 2024 | 46.76% |
August 23, 2024 | 45.75% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-3.96%
Minimum
Sep 26 2022
97.35%
Maximum
Oct 16 2023
41.84%
Average
38.92%
Median
1 Year Total Returns (Daily) Benchmarks
Evaxion Biotech AS | -76.02% |
Amgen Inc | 26.08% |
Viking Therapeutics Inc | 661.5% |
Adaptimmune Therapeutics PLC | 48.11% |
Genfit SA | 94.79% |